Integrin β3 blockade with abciximab and protection from myocardial ischemic events [4] (multiple letters)

JAMA

Volumn 279, Issue 3, 1998, Pages 195-196

  Conrad, M E ^a   Umbreit, J N ^a   Moore, E G ^a   Fischman, D L ^a   Savage, M P ^a  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; INTEGRIN; ANTITHROMBOCYTIC AGENT; BETA3 INTEGRIN; FIBRINOGEN RECEPTOR; IMMUNOGLOBULIN F(AB) FRAGMENT; LEUKOCYTE ANTIGEN; MONOCLONAL ANTIBODY;

HEART INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LETTER; PRIORITY JOURNAL; RECEPTOR BLOCKING; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; NOTE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; INTEGRIN BETA3; INTEGRINS; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; PLATELET MEMBRANE GLYCOPROTEINS;

EID: 0032553990     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.279.3.195     Document Type: Letter

References (0)